STOCK TITAN

Apyx Medical Corporation Stock Price, News & Analysis

APYX Nasdaq

Welcome to our dedicated page for Apyx Medical Corporation news (Ticker: APYX), a resource for investors and traders seeking the latest updates and insights on Apyx Medical Corporation stock.

Apyx Medical Corporation (NASDAQ: APYX) is a surgical aesthetics and advanced energy technology company whose news flow centers on its Helium Plasma Platform Technology products, including Renuvion, the AYON Body Contouring System, and J-Plasma. Company press releases focus on developments in the cosmetic surgery market, the hospital surgical market, and OEM relationships with other medical device manufacturers.

Investors and observers following APYX news will see regular updates on financial performance, such as quarterly and annual revenue results, preliminary unaudited revenue ranges, and segment-level trends in Surgical Aesthetics and OEM revenue. The company also issues guidance updates and discusses factors influencing its revenue mix, including the commercial rollout of AYON and demand for single-use handpieces and generators.

Another key category of Apyx Medical news involves product and regulatory milestones. Recent announcements describe FDA 510(k) clearances and submissions related to the AYON Body Contouring System, as well as international regulatory approvals like the Ministry of Food and Drug Safety clearance in South Korea for the Apyx One console and single-use handpieces. These items highlight how the company is expanding the indications and geographic reach of its platforms.

APYX news also covers capital markets and corporate actions, including proposed and completed public offerings of common stock under an effective Form S-3 shelf registration statement, as reported in 8-K filings and related press releases. Additional items include notices of investor conference participation, inducement equity awards under Nasdaq Listing Rule 5635(c)(4), and information about annual stockholder meetings and governance matters.

This news page aggregates these disclosures so readers can review Apyx Medical’s earnings releases, product launch updates, regulatory submissions, financing transactions, and investor events in one place.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.15%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-28.65%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.4%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.48%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.03%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.08%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.29%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.29%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.63%
Tags

FAQ

What is the current stock price of Apyx Medical Corporation (APYX)?

The current stock price of Apyx Medical Corporation (APYX) is $3.94 as of February 5, 2026.

What is the market cap of Apyx Medical Corporation (APYX)?

The market cap of Apyx Medical Corporation (APYX) is approximately 162.9M.
Apyx Medical Corporation

Nasdaq:APYX

APYX Rankings

APYX Stock Data

162.89M
35.36M
14.55%
43.29%
0.61%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
CLEARWATER

APYX RSS Feed